306 related articles for article (PubMed ID: 19157884)
1. Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists.
Gitto R; De Luca L; Ferro S; Citraro R; De Sarro G; Costa L; Ciranna L; Chimirri A
Bioorg Med Chem; 2009 Feb; 17(4):1640-7. PubMed ID: 19157884
[TBL] [Abstract][Full Text] [Related]
2. Computational studies to discover a new NR2B/NMDA receptor antagonist and evaluation of pharmacological profile.
Gitto R; De Luca L; Ferro S; Occhiuto F; Samperi S; De Sarro G; Russo E; Ciranna L; Costa L; Chimirri A
ChemMedChem; 2008 Oct; 3(10):1539-48. PubMed ID: 18767069
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors.
Gitto R; De Luca L; Ferro S; Buemi MR; Russo E; De Sarro G; Costa L; Ciranna L; Prezzavento O; Arena E; Ronsisvalle S; Bruno G; Chimirri A
J Med Chem; 2011 Dec; 54(24):8702-6. PubMed ID: 22050212
[TBL] [Abstract][Full Text] [Related]
4. CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, a potent selective glycine-site NMDA receptor antagonist.
Baron BM; Cregge RJ; Farr RA; Friedrich D; Gross RS; Harrison BL; Janowick DA; Matthews D; McCloskey TC; Meikrantz S; Nyce PL; Vaz R; Metz WA
J Med Chem; 2005 Feb; 48(4):995-1018. PubMed ID: 15715469
[TBL] [Abstract][Full Text] [Related]
5. Selective NR1/2B N-methyl-D-aspartate receptor antagonists among indole-2-carboxamides and benzimidazole-2-carboxamides.
Borza I; Bozó E; Barta-Szalai G; Kiss C; Tárkányi G; Demeter A; Gáti T; Háda V; Kolok S; Gere A; Fodor L; Nagy J; Galgóczy K; Magdó I; Agai B; Fetter J; Bertha F; Keserü GM; Horváth C; Farkas S; Greiner I; Domány G
J Med Chem; 2007 Mar; 50(5):901-14. PubMed ID: 17290978
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticonvulsant evaluation of N-substituted isoquinoline AMPA receptor antagonists.
Gitto R; De Luca L; Pagano B; Citraro R; De Sarro G; Costa L; Ciranna L; Chimirri A
Bioorg Med Chem; 2008 Mar; 16(5):2379-84. PubMed ID: 18077172
[TBL] [Abstract][Full Text] [Related]
7. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
[TBL] [Abstract][Full Text] [Related]
8. Design of antagonists for NMDA and AMPA receptors.
Bolshakov KV; Kim KH; Potapjeva NN; Gmiro VE; Tikhonov DB; Usherwood PN; Mellor IR; Magazanik LG
Neuropharmacology; 2005 Aug; 49(2):144-55. PubMed ID: 15996563
[TBL] [Abstract][Full Text] [Related]
9. Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor.
Jansen M; Potschka H; Brandt C; Löscher W; Dannhardt G
J Med Chem; 2003 Jan; 46(1):64-73. PubMed ID: 12502360
[TBL] [Abstract][Full Text] [Related]
10. Tricyclic indole-2-carboxylic acids: highly in vivo active and selective antagonists for the glycine binding site of the NMDA receptor.
Katayama S; Ae N; Kodo T; Masumoto S; Hourai S; Tamamura C; Tanaka H; Nagata R
J Med Chem; 2003 Feb; 46(5):691-701. PubMed ID: 12593650
[TBL] [Abstract][Full Text] [Related]
11. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
[TBL] [Abstract][Full Text] [Related]
12. Oxamides as novel NR2B selective NMDA receptor antagonists.
Barta-Szalai G; Borza I; Bozó E; Kiss C; Agai B; Proszenyák A; Keseru GM; Gere A; Kolok S; Galgóczy K; Horváth C; Farkas S; Domány G
Bioorg Med Chem Lett; 2004 Aug; 14(15):3953-6. PubMed ID: 15225705
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological characterization of 3-substituted 1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors. Part 2.
Gitto R; De Luca L; Ferro S; Buemi MR; Russo E; De Sarro G; Chisari M; Ciranna L; Chimirri A
J Med Chem; 2012 Dec; 55(23):10532-9. PubMed ID: 23140383
[TBL] [Abstract][Full Text] [Related]
14. (E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists.
Balsamini C; Bedini A; Diamantini G; Spadoni G; Tontini A; Tarzia G; Di Fabio R; Feriani A; Reggiani A; Tedesco G; Valigi R
J Med Chem; 1998 Mar; 41(6):808-20. PubMed ID: 9526557
[TBL] [Abstract][Full Text] [Related]
15. In vitro characterization of novel NR2B selective NMDA receptor antagonists.
Kiss L; Cheng G; Bednar B; Bednar RA; Bennett PB; Kane SA; McIntyre CJ; McCauley JA; Koblan KS
Neurochem Int; 2005 May; 46(6):453-64. PubMed ID: 15769547
[TBL] [Abstract][Full Text] [Related]
16. Indole-2-carboxamidines as novel NR2B selective NMDA receptor antagonists.
Borza I; Kolok S; Ignácz-Szendrei G; Greiner I; Tárkányi G; Galgóczy K; Horváth C; Farkas S; Domány G
Bioorg Med Chem Lett; 2005 Dec; 15(24):5439-41. PubMed ID: 16213709
[TBL] [Abstract][Full Text] [Related]
17. Substituted analogues of GV150526 as potent glycine binding site antagonists in animal models of cerebral ischemia.
Di Fabio R; Conti N; De Magistris E; Feriani A; Provera S; Sabbatini FM; Reggiani A; Rovatti L; Barnaby RJ
J Med Chem; 1999 Sep; 42(18):3486-93. PubMed ID: 10479281
[TBL] [Abstract][Full Text] [Related]
18. N'-Phenylindol-3-ylglyoxylohydrazide derivatives: synthesis, structure-activity relationships, molecular modeling studies, and pharmacological action on brain benzodiazepine receptors.
Da Settimo A; Primofiore G; Da Settimo F; Marini AM; Novellino E; Greco G; Gesi M; Martini C; Giannaccini G; Lucacchini A
J Med Chem; 1998 Sep; 41(20):3821-30. PubMed ID: 9748357
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Biological Evaluation of 3-Benzazepin-1-ols as NR2B-Selective NMDA Receptor Antagonists.
Tewes B; Frehland B; Schepmann D; Schmidtke KU; Winckler T; Wünsch B
ChemMedChem; 2010 May; 5(5):687-95. PubMed ID: 20340125
[TBL] [Abstract][Full Text] [Related]
20. Targeting GluN2B-containing N-Methyl-D-aspartate receptors: design, synthesis, and binding affinity evaluation of novel 3-substituted indoles.
Buemi MR; De Luca L; Ferro S; Gitto R
Arch Pharm (Weinheim); 2014 Aug; 347(8):533-9. PubMed ID: 24862313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
